CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 81 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05523219
NCT05523219N/ACompleted

Prospective Observational Study for the Evaluation of VEOFIX Varisation Staples

Societe dEtude, de Recherche et de Fabrication·observational·Posted Aug 31, 2022·Updated May 1, 2024

In Brief

An observational study for Hallux Valgus. Completed, enrolled 81 participants across 1 site.

Detailed Summary

This clinical investigation was led as a post-market clinical follow-up study (post-market device development stage). Therefore, its objectives were as follows: * To assess functional clinical score's evolution, * To evaluate patient's satisfaction * To confirm safety of varisation staples The target population for this study was any adult patient implanted with VEOFIX varisation staples in their intended uses between 15/02/2021 and 15/05/2021. Patients were implanted and followed as per standard of care led in the investigational site. The following regulation and guidelines were followed for this investigation: * Standard ISO 14155:2020 "Good Clinical Practice"undirectly applicable; * Regulation (UE) 2016/679 (RGPD) ; * Regulation (UE) 2017/745 (MDR) ; * MEDDEV 2.12.1; * Local regulation (loi " jardé ", loi " informatique et libertés "). As per its design, the investigation is considered as involving human beings, and therefore require submission to an ethic committee or declaration to a Competent Authority (ANSM) and CPP. This study was registered on CPP (CPP Ile de France VII).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHallux Valgus
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedAug 31, 2022
Enrollment StartFeb 15, 2021
Primary CompletionMar 2, 2022
Study CompletionJun 7, 2022
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 3.8 years ago